Key facts
- Philips' second-quarter core profit margin exceeded analyst expectations.
- Comparable order intake decreased by 1% as large orders were postponed to the third quarter.
Philips CEO Roy Jakobs stated that delayed U.S. orders and market pressure in China impacted the company's second-quarter results. Despite this, Philips lifted its full-year margin outlook, benefiting from U.S. tariff refunds.

The commentary from Philips' CEO highlights the complex interplay of global market dynamics, including supply chain timing issues and regulatory shifts in key markets like China, which can significantly affect corporate earnings and outlooks.
Philips' second-quarter results were impacted by delayed orders in the U.S. and market pressure in China, according to CEO Roy Jakobs. The healthcare tech group reported a core profit margin that surpassed analyst expectations, partly due to U.S. tariff refunds. However, comparable order intake declined by 1% as significant, multi-year contracts were shifted into the third quarter. Jakobs characterized these delays as a timing issue inherent in large deals. Analysts also pointed to ongoing challenges in the Chinese market, exacerbated by a new government policy mandating centralized procurement of medical equipment. This policy has reportedly caused market turmoil and degrowth, leading Philips to anticipate a more structurally challenging environment in China moving forward.